AbbVie (NYSE:ABBV) has made another offer to acquire Shire (NASDAQ:SHPG) in a bid to offset looming patent risk and lower its tax rate.

Since Shire is generating a significant amount of free cash and currently doesn't pay much in the way of a dividend, acquiring the company should give AbbVie financial flexibility that will allow it to reward shareholders.

In the following slideshow, you'll learn why I believe that dividend investors should applaud if AbbVie succeeds in courting Shire.